Tracey G Simon

Tracey G Simon

UNVERIFIED PROFILE

Are you Tracey G Simon?   Register this Author

Register author
Tracey G Simon

Tracey G Simon

Publications by authors named "Tracey G Simon"

Are you Tracey G Simon?   Register this Author

42Publications

755Reads

35Profile Views

When less is more: dosing simvastatin in decompensated cirrhosis.

Authors:
Tracey G Simon

Lancet Gastroenterol Hepatol 2020 Jan 10;5(1):3-5. Epub 2019 Oct 10.

Division of Gastroenterology and Hepatology, Department of Medicine and Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30321-8DOI Listing
January 2020

Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.

Clin Gastroenterol Hepatol 2019 Dec 9;17(13):2776-2784.e4. Epub 2019 May 9.

Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston Massachusetts; Harvard Medical School, Boston Massachusetts; Clinical and Translational Epidemiology Unit (CTEU), Massachusetts General Hospital, Boston Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565193049
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2019.04.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842070PMC
December 2019

Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women.

Am J Gastroenterol 2019 Dec;114(12):1870-1877

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14309/ajg.0000000000000450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893135PMC
December 2019

Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.

Ann Intern Med 2019 Sep 20;171(5):318-327. Epub 2019 Aug 20.

Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden, Örebro University Hospital, Örebro, Sweden, and Columbia University College of Physicians and Surgeons, New York, New York (J.F.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M18-2753DOI Listing
September 2019

Dietary Patterns and Risk of Hepatocellular Carcinoma Among U.S. Men and Women.

Hepatology 2019 Aug 5;70(2):577-586. Epub 2019 Mar 5.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.30362
Publisher Site
http://dx.doi.org/10.1002/hep.30362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545168PMC
August 2019

Meat intake and risk of hepatocellular carcinoma in two large US prospective cohorts of women and men.

Int J Epidemiol 2019 Jul 13. Epub 2019 Jul 13.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ije/dyz146DOI Listing
July 2019

Reply.

Clin Gastroenterol Hepatol 2019 Jul 25. Epub 2019 Jul 25.

Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.07.041DOI Listing
July 2019

The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study.

Liver Int 2019 Jun 17;39(6):1022-1026. Epub 2019 Feb 17.

Evans Department of Medicine, Section of Gastroenterology, Boston University School of Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/liv.14039
Publisher Site
http://dx.doi.org/10.1111/liv.14039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535115PMC
June 2019

A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men.

Cancer Prev Res (Phila) 2019 Jun 30;12(6):367-374. Epub 2019 Apr 30.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-18-0511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548636PMC
June 2019

Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin-In Reply.

JAMA Oncol 2019 Jun;5(6):911-912

Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.0630DOI Listing
June 2019

Aspirin Use and the Risk of Cancer-In Reply.

JAMA Oncol 2019 Jun;5(6):913

Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.0633DOI Listing
June 2019

A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women.

Int J Cancer 2019 May 22. Epub 2019 May 22.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32423DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872903PMC
May 2019

Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.

JAMA Oncol 2018 12;4(12):1683-1690

Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.4154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440745PMC
December 2018

The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.

Int J Cardiol 2018 Nov 26;270:245-252. Epub 2018 May 26.

Harvard Medical School, Boston, MA, United States; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2018.05.087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139264PMC
November 2018

The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease.

Antivir Ther 2016 6;21(3):185-94. Epub 2015 Oct 6.

Liver Center, Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2997DOI Listing
January 2018

The MELD-Plus: A generalizable prediction risk score in cirrhosis.

PLoS One 2017 25;12(10):e0186301. Epub 2017 Oct 25.

Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186301PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656314PMC
November 2017

Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction.

Obesity (Silver Spring) 2017 08;25(8):1313-1316

Liver Center, Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/oby.21879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648006PMC
August 2017

MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD).

Hepatol Commun 2017 Jul 22;1(5):429-438. Epub 2017 May 22.

Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep4.1051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659323PMC
July 2017

Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.

Dig Dis Sci 2016 12 6;61(12):3425-3435. Epub 2016 Oct 6.

Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-016-4330-zDOI Listing
December 2016

Reply.

Hepatology 2016 06 26;63(6):2066-7. Epub 2015 Nov 26.

Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28136DOI Listing
June 2016

Association of Model for End-Stage Liver Disease Score and Mortality in Trauma Patients With Chronic Liver Disease.

JAMA Surg 2016 Jan;151(1):41-8

The Nathan E. Hellman Memorial Laboratory, Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2015.3114DOI Listing
January 2016

The new hepatitis C virus bottleneck: Can delaying therapy be justified?

Hepatology 2015 Sep 14;62(3):666-7. Epub 2015 Jul 14.

Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27931DOI Listing
September 2015

Massive intravascular hemolysis from Clostridium perfringens septicemia: a review.

J Intensive Care Med 2014 Nov-Dec;29(6):327-33. Epub 2013 Sep 9.

The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RL, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0885066613498043DOI Listing
July 2015

Reduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes.

Dig Dis Sci 2015 Jul 28;60(7):2190-5. Epub 2015 Feb 28.

Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-015-3578-zDOI Listing
July 2015

Reply to: "Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis".

J Hepatol 2015 Jul 26;63(1):279. Epub 2015 Feb 26.

Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278150013
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2015.02.028DOI Listing
July 2015

Initial Assessment and Resuscitation in Nonvariceal Upper Gastrointestinal Bleeding.

Gastrointest Endosc Clin N Am 2015 Jul 18;25(3):429-42. Epub 2015 Apr 18.

Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.giec.2015.02.006DOI Listing
July 2015

Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes.

World J Gastroenterol 2015 Jul;21(27):8293-303

Tracey G Simon, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i27.8293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507099PMC
July 2015

Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C.

J Hepatol 2015 Jan 15;62(1):18-23. Epub 2014 Aug 15.

Liver Center, Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2014.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272642PMC
January 2015

Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.

Eur J Radiol 2012 Dec 24;81(12):4167-72. Epub 2012 Jul 24.

Department of Diagnostic Imaging, Rhode Island Hospital/The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI 02903, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2012.06.007DOI Listing
December 2012